Grant Information
| Knowledge Area | Subject of Investigation | Field of Science | Percent |
|---|---|---|---|
| 204 - Plant Product Quality and Utility (Preharvest) | 920 - Orange | 1080 - Genetics (excludes breeding) | 40% |
| 203 - Plant Biological Efficiency and Abiotic Stresses Affecting Plants | 910 - Grapefruit | 1000 - Biochemistry and biophysics | 30% |
| 212 - Pathogens and Nematodes Affecting Plants | 999 - Citrus, general/other | 1160 - Pathology | 30% |
Plant replicated trial with 8 plants of each of numerous citranges (from a well-characterized mapping population), other poncirus hybrids and standard cultivars. Material will be at USDA/ARS Picos Farm where HLB and ACP are rampant and will be screened in response to natural exposure.
This project is related to Objective 1: Create new genetic combinations of citrus, Objective 2: Screen germplasm for important traits and select superior individuals, Sub objective 1 D: Create new scions and rootstocks with potential resistance to huanglongbing (HLB) and citrus bacterial canker (CBC) by genetic transformation. More than 120 citranges, from a well-characterized mapping population, and other trifoliate hybrids (+ sweet orange standards) have been planted in a replicated trial in collaboration with University of Florida and University of California/Riverside. Plants are being monitored for Liberibacter development and HLB symptoms. A USDA/ARS advanced selection which is 1/16th Poncirus, with commercial quality fruit, is performing extremely well. Data from this trial should provide information on markers and perhaps genes associated with huanglongbing (HLB) resistance, for use in transgenic and conventional breeding. The University of California-Riverside has genotyped these plants by sequencing.